Abstract

ObjectivesPredicting adherence to immunosuppressive medication (IM) is important to improve and design future prospective, personalized interventions in Chinese renal transplant patients (RTPs).MethodsA retrospective, multicenter, cross-sectional study was performed in 1,191 RTPs from October 2020 to February 2021 in China. The BAASIS was used as the standard to determine the adherence of the patients. Variables of the combined theory, including the general data, the HBM, the TPB, the BMQ, the PSSS and the GSES, were used to build the models. The machine learning (ML) models included LR, RF, MLP, SVM, and XG Boost. The SHAP method was used to evaluate the contribution of predictors to predicting the risk of IM non-adherence in RTPs.ResultsThe IM non-adherence rate in the derivation cohort was 38.5%. Ten predictors were screened to build the model based on the database. The SVM model performed better among the five models, with sensitivity of 0.59, specificity of 0.73, and average AUC of 0.75. The SHAP analysis showed that age, marital status, HBM-perceived barriers, use pill box after transplantation, and PSSS-family support were the most important predictors in the prediction model. All of the models had good performance validated by external data.ConclusionsThe IM non-adherence rate of RTPs was high, and it is important to improve IM adherence. The model developed by ML technology could identify high-risk patients and provide a basis for the development of relevant improvement measures.

Highlights

  • Over past decades, with improved immunosuppressive therapy and surgical techniques, improvements in graft survival have been achieved in the early-post transplantation phase [1,2,3]

  • immunosuppressive medication (IM) nonadherence is a major issue among transplant recipients that can lead to misdiagnosis, rejection, graft loss or death

  • This study aimed to examine the correlation between variables of the combined theory and non-adherence behavior in renal transplant patients (RTPs)

Read more

Summary

Introduction

With improved immunosuppressive therapy and surgical techniques, improvements in graft survival have been achieved in the early-post transplantation phase [1,2,3]. Successful long-term kidney graft outcomes remain suboptimal. The therapeutic regimens of renal transplant patients (RTPs) typically involve taking various prescribed medications per day, including immunosuppressive medication (IM). They need to receive immunosuppressant therapy for as long as their grafts continue to function. Successful long-term kidney graft outcomes remain suboptimal, with IM non-adherence considered as an important contributing factor. Non-adherence is common, occurring in 23.21–44.2% of Chinese renal transplant recipients in our previous studies [4,5,6]. IM nonadherence is a major issue among transplant recipients that can lead to misdiagnosis, rejection, graft loss or death

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call